Skip to content

Effectiveness of External Vibration for Pain Relief During Intravenous Access in Adult Patients

Effectiveness of External Vibration for Pain Relief During Peripheral Intravenous Cannulation in Adult Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03619135
Enrollment
100
Registered
2018-08-07
Start date
2016-10-17
Completion date
2017-08-24
Last updated
2019-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management, Anxiety

Keywords

Pain, Anxiety, intravenous access

Brief summary

A large number of dentoalveolar (tooth extraction) procedures performed by Oral and Maxillofacial Surgeons utilize intravenous sedation. Procedures commonly performed may include surgical removal of teeth, bone grafting, surgical placement of dental implants, and removal of cysts or tumors from the jaws, among others. Obtaining peripheral intravevenous (IV) cannulation often proves to be a very stressful and anxious event for the patient. The anxiety and stress from the venipuncture alone affects not only the psychological stability of the patient, but also the patient's physiology. The Buzzy vibration external stimulation device has shown to be an effective tool in pediatric venipunture procedures. The aim of this study is to investigate the effects of the Buzzy stimulation device in pain and anxiety reduction during peripheral intravenous cannulation in an adult population. Enrollees in this study will be patients who will undergo dental surgery with intravenous sedation. The patients who are enrolled will receive an IV either with or without the Buzzy. The Buzzy is a small vibration device which will be placed next to the IV placement site.

Detailed description

The participants will be randomized into two groups, those who use the Buzzy system (experimental), and routine IV start (control). Prior to knowing their group, all patients will answer the Before Intravenous Catheterization portion of the form in order to eliminate bias. After this portion is complete, their group (experimental vs control) will be determined from opening a blinded envelope. A tourniquet will be placed, followed by the Buzzy stimulation device (if in the experimental group). An alcohol swab will be used and then a 22 gauge IV catheter will be inserted, connected to fluids, and secured with tape. The antecubital fossa or the dorsal hand/wrist will be the only sites used in the study. All participants will fill out the post-insertion questions on the form and those patients that used the Buzzy system will then fill out the several specific questions related to the experimental group. This will conclude the patient's involvement in the study. The patient will then continue with treatment as planned. We will plan to exclude cases where the IV is not obtained on the first attempt, if a smaller or larger gauge IV catheter is required, or if an insertion site not listed above is required. The case will be excluded if adjunctive steps are taken to obtain IV access (i.e. Oral sedation, nitrous oxide, heat packs).

Interventions

DEVICEBuzzy

The Buzzy is a reusable device that applies vibration to the skin surface to override the body's gate control pain pathway. It has been used effectively to reduce the discomfort of intravenous cannulation (IV placement) in pediatric patients. Also, it has been utilized to reduce the discomfort of injections in pediatric and adult patients. We are preforming this study to evaluate the effectiveness of the Buzzy in reducing the discomfort associated with intravenous cannluation (IV placement) in adults.

OTHERPlacebo

No use of the Buzzy (standard IV access techniques)

Sponsors

Kyle Stein
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18 and 40. * Eligible for third molar removal with sedation.

Exclusion criteria

* Not eligible for surgery. * Not eligible for sedation.

Design outcomes

Primary

MeasureTime frameDescription
Change in PainBaseline and after IV accessPain is measured on a 10 point visual analog scale with 0 being no pain and 10 being the worst pain imaginable. A higher score is a worse outcome.
Change in AnxietyBaseline and after IV accessAnxiety is measured on a 10 point visual analog scale with 0 being no anxiety and 10 being the worst anxiety imaginable. A higher score is a worse outcome.

Countries

United States

Participant flow

Participants by arm

ArmCount
Use of Buzzy Device
The Buzzy device was used for IV access for this arm. Buzzy: The Buzzy is a reusable device that applies vibration to the skin surface to override the body's gate control pain pathway. It has been used effectively to reduce the discomfort of intravenous cannulation (IV placement) in pediatric patients. Also, it has been utilized to reduce the discomfort of injections in pediatric and adult patients. We are preforming this study to evaluate the effectiveness of the Buzzy in reducing the discomfort associated with intravenous cannluation (IV placement) in adults.
50
Control
No Buzzy device was used - standard IV access for this arm. Placebo: No use of the Buzzy (standard IV access techniques)
50
Total100

Baseline characteristics

CharacteristicControlTotalUse of Buzzy Device
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
50 Participants100 Participants50 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
50 participants100 participants50 participants
Sex: Female, Male
Female
26 Participants55 Participants29 Participants
Sex: Female, Male
Male
24 Participants45 Participants21 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 500 / 50
other
Total, other adverse events
0 / 500 / 50
serious
Total, serious adverse events
0 / 500 / 50

Outcome results

Primary

Change in Anxiety

Anxiety is measured on a 10 point visual analog scale with 0 being no anxiety and 10 being the worst anxiety imaginable. A higher score is a worse outcome.

Time frame: Baseline and after IV access

ArmMeasureValue (MEAN)Dispersion
Use of Buzzy DeviceChange in Anxiety1.70 score on a scaleStandard Deviation 1.743
ControlChange in Anxiety1.84 score on a scaleStandard Deviation 1.796
Primary

Change in Pain

Pain is measured on a 10 point visual analog scale with 0 being no pain and 10 being the worst pain imaginable. A higher score is a worse outcome.

Time frame: Baseline and after IV access

ArmMeasureValue (MEAN)Dispersion
Use of Buzzy DeviceChange in Pain1.55 score on a scaleStandard Deviation 1.119
ControlChange in Pain1.76 score on a scaleStandard Deviation 1.401

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026